Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...

In this roundtable webinar, discover how scientists improve tumor-informed minimal residual disease (MRD) testing for ...

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

SAGA Metals Corp.('SAGA' or the 'Company') (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company ...

Cash Burn -- $50.2 million in 2025, an improvement from $57.8 million in 2024 due to lower headcount and development costs.

Klotho Neurosciences, Inc. ("Klotho" or the Company) announces the development of two genomics-based diagnostic tests that will be utilized in Klotho's clinical trials and to be provided as a service ...

Industry veteran brings extensive life sciences commercial leadership experience from Biotechne, Miltenyi Biotec, and Adaptive BiotechnologiesEMERYVILLE, Calif., March 5, 2026 /PRNewswire/ -- ...

Targeted Protein Degradation (TPD) is an emerging drug modality that enables specific degradation of protein targets, offering a powerful approach to tackle previously undruggable targets including ...

Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced the launch of a new genomics diagnostics initiative centered on two epigenetics-based tests designed to support its clinical trials and expand ...